SCHEMBL7924636

SCHEMBL7924636

N#Cc1cccc(-c2ccc(CCC(Cc3ccc(-c4ccccc4)cc3)C(=O)O)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 3/20 0.65
MMP13 P45452 3/20 0.65
FOLH1 Q04609 1/20 0.55
MME P08473 3/20 0.53
FFAR1 O14842 3/20 0.47
ACE P12821 1/20 0.46
CPA1 P15085 1/20 0.46
ACE2 Q9BYF1 1/20 0.46
XDH P47989 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
CTSC P53634 2/20 0.45
ADAMTS4 O75173 1/20 0.45
FFAR4 Q5NUL3 2/20 0.44
PTPN5 P54829 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP14 P50281 1/20 0.43
GPR34 Q9UPC5 1/20 0.43
AKR1B1 P15121 1/20 0.43
CPA3 P15088 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467200 0.93 MMP12 (0.60) MMP12MMP13FOLH1MMEFFAR1
SCHEMBL3466325 0.91 FFAR1 (0.57) MMP12MMP13FOLH1FFAR1ADAMTS4
SCHEMBL7928277 0.89 MMP12 (0.64) MMP12MMP13FOLH1MMEFFAR1
SCHEMBL7932591 0.88 MMP12 (0.63) MMP12MMP13FOLH1MMEFFAR1
SCHEMBL7923446 0.83 MMP12 (0.57) MMP12MMP13FOLH1MMEFFAR1
SCHEMBL3465875 0.83 MMP12 (0.65) MMP12MMP13MMEFFAR1ACE
SCHEMBL7917889 0.82 MMP12 (0.55) MMP12MMP13FOLH1MMEFFAR1
SCHEMBL3467249 0.81 MMP12 (0.54) MMP12MMP13FOLH1FFAR1ADAMTS4
SCHEMBL3466565 0.81 GPR34 (0.54) MMP12MMP13FFAR1ADAMTS4FFAR4
SCHEMBL12646477 0.80 FFAR1 (0.70) MMP12MMP13MMEFFAR1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed